COMPASS Pathways plc (CMPS)
NMS · Medical Care Facilities
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
Peers in Medical Care Facilities
All in industry →HCA Healthcare, Inc.
Tenet Healthcare Corporation
Fresenius Medical Care AG
The Ensign Group, Inc.
Universal Health Services, Inc.
Encompass Health Corporation
DaVita Inc.
PACS Group, Inc.
Chemed Corporation
Option Care Health, Inc.
Recent press releases
COMPASS Pathways plc has not issued a press release in this window.
SEC filings
All filings →COMPASS Pathways plc has not filed an SEC document in this window.
Insider trades
All insider trades →COMPASS Pathways plc has no reported insider trades in the last 90 days.